Anti-inflammatory effects of curcumin in a murine model of chronic asthma

Allergologia et Immunopathologia

Volumn 40, Issue 4, 2012, Pages 210-214

  Karaman, M ^a   Firinci, F ^a   Cilaker, S ^a   Uysal, P ^a   Tugyan, K ^a   Yilmaz, O ^a   Uzuner, N ^a   Karaman, O ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Antiinflammatory; Chronic asthma; Curcumin; Mouse; Treatment

Indexed keywords

CURCUMIN; DEXAMETHASONE; DIMETHYL SULFOXIDE; OVALBUMIN; SODIUM CHLORIDE;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIZATION; FEMALE; HISTOPATHOLOGY; MICROSCOPY; MOUSE; NEBULIZATION; NONHUMAN; RESPIRATORY EPITHELIUM; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; CURCUMIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LUNG; MICE; MICE, INBRED BALB C; OVALBUMIN; RESPIRATORY MUCOSA;

EID: 84863781250     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2011.04.006     Document Type: Article

References (24)

1. Rabe K.F., Adachi M., Lai C.K., Soriano J.B., Vermeire P.A., Weiss K.B., et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004, 114:40-47.
2. Boulet L.P. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patient. Chest 1998, 113:587-592.
3. Chan P.W., DeBruyne J.A. Parental concern towards the use of inhaled therapy in children with chronic asthma. Pediatr Int 2000, 42:547-551.
4. Ernst E. Complementary therapies for asthma: what patients use?. J Asthma 1998, 35:667-671.
5. Babayigit A., Olmez D., Karaman O., Ozogul C., Yilmaz O., Kivcak B., et al. Effects of Ginkgo biloba on airway histology in a mouse model of chronic asthma. Allergy Asthma Proc 2009, 30:186-191.
6. Huntley A., Ernst E. Herbal medicines for asthma: a systematic review. Thorax 2000, 55:925-929.
7. Blanc P.D., Trupin L., Earnest G., Katz P.P., Yelin E.H., Eisner M.D. Alternative therapies among adults with a reported diagnosis of asthma or rhinosinusitis: data from a population-based survey. Chest 2001, 120:1461-1467.
8. Ammon H.P., Wahl M.A. Pharmacology of Curcuma longa. Planta Med 1991, 57:1-17.
9. Srimal R.C., Dhawan B.N. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 1973, 25:447-452.
10. Huang M.T., Smart R.C., Wong C.Q., Conney A.H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1988, 48:5941-5946.
11. Rao C.V., Rivenson A., Simi B., Reddy B.S. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 1995, 55:259-266.
12. Joe B., Lokesh B.R. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1994, 1224:255-263.
13. Reddy A.C., Lokesh B.R. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol Cell Biochem 1994, 137:1-8.
14. Mazumder A., Raghavan K., Weinstein J., Kohn K.W., Pommier Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 1995, 49:1165-1170.
15. Huang H.C., Jan T.R., Yeh S.F. Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur J Pharmacol 1992, 221:381-384.
16. Chan M.M. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 1995, 49:1551-1556.
17. Temelkovski J., Hogan S.P., Shepherd D.P., Foster P.S., Kumar R.K. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998, 53:849-856.
18. Olmez D., Babayigit A., Uzuner N., Erbil G., Karaman O., Yilmaz O., et al. Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma. Exp Lung Res 2008, 34:501-511.
19. Moon D.O., Kim M.O., Lee H.J., Choi Y.H., Park Y.M., Heo M.S., et al. Curcumin attenuates ovalbumin-induced airway inflammation by regulating nitric oxide. Biochem Biophys Res Commun 2008, 375:275-279.
20. Bergeron C., Boulet L.P. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest 2006, 129:1068-1087.
21. Douglas D.E. 4,4'-Diacetyl curcumin-in-vitro histamine-blocking activity. J Pharm Pharmacol 1993, 45:766.
22. Ju H.R., Wu H.Y., Nishizono S., Sakono M., Ikeda I., Sugano M., et al. Effects of dietary fats and curcumin on IgE-mediated degranulation of intestinal mast cells in brown Norway rats. Biosci Biotechnol Biochem 1996, 60:1856-1860.
23. Skrzypczak-Jankun E., McCabe N.P., Selman S.H., Jankun J. Curcumin inhibits lipoxygenase by binding to its central cavity: theoretical and X-ray evidence. Int J Mol Med 2000, 6:521-526.
24. Ram A., Das M., Ghosh B. Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biol Pharm Bull 2003, 26:1021-1024.